1. Home
  2. CRI vs TMDX Comparison

CRI vs TMDX Comparison

Compare CRI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRI
  • TMDX
  • Stock Information
  • Founded
  • CRI 1865
  • TMDX 1998
  • Country
  • CRI United States
  • TMDX United States
  • Employees
  • CRI N/A
  • TMDX N/A
  • Industry
  • CRI Apparel
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CRI Consumer Discretionary
  • TMDX Health Care
  • Exchange
  • CRI Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • CRI 1.9B
  • TMDX 2.1B
  • IPO Year
  • CRI 2003
  • TMDX 2019
  • Fundamental
  • Price
  • CRI $54.73
  • TMDX $56.73
  • Analyst Decision
  • CRI Hold
  • TMDX Buy
  • Analyst Count
  • CRI 6
  • TMDX 11
  • Target Price
  • CRI $67.67
  • TMDX $116.10
  • AVG Volume (30 Days)
  • CRI 1.3M
  • TMDX 2.6M
  • Earning Date
  • CRI 02-25-2025
  • TMDX 02-24-2025
  • Dividend Yield
  • CRI 5.85%
  • TMDX N/A
  • EPS Growth
  • CRI 15.51
  • TMDX N/A
  • EPS
  • CRI 6.33
  • TMDX 0.94
  • Revenue
  • CRI $2,842,254,000.00
  • TMDX $401,090,000.00
  • Revenue This Year
  • CRI N/A
  • TMDX $81.61
  • Revenue Next Year
  • CRI N/A
  • TMDX $22.52
  • P/E Ratio
  • CRI $8.65
  • TMDX $60.54
  • Revenue Growth
  • CRI N/A
  • TMDX 109.09
  • 52 Week Low
  • CRI $50.25
  • TMDX $55.00
  • 52 Week High
  • CRI $88.03
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • CRI 52.77
  • TMDX 35.29
  • Support Level
  • CRI $52.94
  • TMDX $58.40
  • Resistance Level
  • CRI $54.69
  • TMDX $67.80
  • Average True Range (ATR)
  • CRI 1.67
  • TMDX 4.65
  • MACD
  • CRI 0.16
  • TMDX -0.46
  • Stochastic Oscillator
  • CRI 67.47
  • TMDX 6.32

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of Carter's sales are in the U.S. and through Carter's brand. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: